Back | Next |
home / stock / pdsb / pdsb message board
Subject | By | Source | When |
---|---|---|---|
$PDSB PDS BIOTECHNOLOGY CORP | MiamiGent | investorshub | 11/14/2022 3:58:00 PM |
Yesss another good trade | starkd748 | investorshub | 11/14/2022 2:42:26 PM |
What really stands out from PR this morning; PDS0101 | James salmon | investorshub | 10/27/2022 2:01:38 PM |
https://finance.yahoo.com/news/pds-biotech-announces-clinical-trial-13000075 | Bertsllc | investorshub | 02/15/2022 2:08:43 PM |
GAP FILLED! | Bertsllc | investorshub | 01/21/2022 2:52:13 PM |
https://investorshub.advfn.com/uimage/uploads/2022/1/20/fnllzScreen Shot 01 | Bertsllc | investorshub | 01/20/2022 8:36:29 PM |
Sorry for the lengthy post but I believe | Desert dweller | investorshub | 01/13/2022 7:29:52 PM |
PDS0203 combines the utility of the Versamune® platform | Esa | investorshub | 11/27/2021 9:03:03 PM |
$PDSB...$12.53...Psar flipped Bullish as the MACD Crosses Positive... | georgie18 | investorshub | 11/02/2021 11:38:29 AM |
800% gain on$ PDSB is my personal green | Stockrocketer | investorshub | 11/01/2021 3:47:52 PM |
5 countb9n the ELLIOTT WAVE | starkd748 | investorshub | 10/23/2021 2:51:47 PM |
Weird sell off today. Oh well, nice adds. | fitzwell11 | investorshub | 10/16/2021 12:37:11 AM |
Same | fitzwell11 | investorshub | 10/15/2021 4:57:11 PM |
Certainly is now, so just added | James salmon | investorshub | 10/15/2021 4:53:44 PM |
Nice pullback for adds | fitzwell11 | investorshub | 10/01/2021 5:33:56 PM |
Its a keeper | Bertsllc | investorshub | 09/24/2021 2:06:18 PM |
What a ride. Can't believe I sold half | Jdanger 2 | investorshub | 09/23/2021 10:23:15 PM |
Enjoying the ride yet ;-) | Bertsllc | investorshub | 09/23/2021 8:02:21 PM |
BREAKOUT! | Bertsllc | investorshub | 09/23/2021 4:15:38 PM |
Chuggin along | Planopenny | investorshub | 09/23/2021 2:17:25 PM |
News, Short Squeeze, Breakout and More Instantly...
PDS Biotechnology Corporation Company Name:
PDSB Stock Symbol:
NYSE Market:
PDS Biotechnology Corporation Website:
Unique mechanism of action of the combination of PDS01ADC and Versamune ® results in 3-year survival of 75% and 75% overall response rate in advanced head and neck cancer trial As a result, Company to focus late-stage clinical strategy on triple combination of PDS01ADC,...
Cano Health Inc. Class A (CANOQ) is expected to report for Q4 2023 Cathay Pacific Airways Ltd. ADR (CPCAY) is expected to report for Q4 2023 NeuroSense Therapeutics Ltd. (NRSN) is expected to report for quarter end 2023-12-31 Bayerische Motoren Werke AG (BAMXF) is expected to report f...
PRINCETON, N.J., March 20, 2024 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a clinical-stage immunotherapy company developing a growing pipeline of targeted cancer immunotherapies and infectious disease vaccines ba...